Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis

Jeanine D'Armiento, Kazushi Imai, John Schiltz, Natalya Kolesnekova, David Sternberg, Kathleen Benson, Annie Pardo, Moises Selman, Theresa Smolarek, Murty Vundavalli, Joshua Sonnet, Matthias Szabolcs, Kiran Chada

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


The normal expression pattern of HMGA2, an architectural transcription factor, is primarily restricted to cells of the developing mesenchyme before their overt differentiation during organogenesis. A detailed in situ hybridization analysis showed that the undifferentiated mesoderm of the embryonic lung expressed Hmga2 but it was not expressed in the newborn or adult lung. Previously, HMGA2 was shown to be misexpressed in a number of benign, differentiated mesenchymal tumors including lipomas, uterine leiomyomas, and pulmonary chondroid hamartomas. Here, we show that HMGA2 is misexpressed in pulmonary lymphangiomyomatosis (LAM), a severe disorder of unknown etiology consisting of lymphatic smooth muscle cell proliferation that results in the obstruction of airways, lymphatics, and vessels. Immunohistochemistry was done with antibodies to HMGA2 and revealed expression in lung tissue samples obtained from 21 patients with LAM. In contrast, HMGA2 was not expressed in sections of normal adult lung or other proliferative interstitial lung diseases, indicating that the expression of HMGA2 in LAM represents aberrant gene activation and is not due solely to an increase in cellular proliferation. In vivo studies in transgenic mice show that misexpression of HMGA2 in smooth muscle cells resulted in increased proliferation of these cells in the lung surrounding the epithelial cells. Therefore, similar to the other mesenchymal neoplasms, HMGA2 misexpression in the smooth muscle cell leads to abnormal proliferation and LAM tumorigenesis. These results suggest that HMGA2 plays a central role in the pathogenesis of LAM and is a potential candidate as a therapeutic target.

Original languageEnglish (US)
Pages (from-to)1902-1909
Number of pages8
JournalCancer Research
Issue number5
StatePublished - Mar 1 2007

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis'. Together they form a unique fingerprint.

Cite this